Effectiveness of St John's wort in major depression: A randomized controlled trial

JAMA

Volumn 285, Issue 15, 2001, Pages 1978-1986

  Shelton, Richard C ^a   Keller, Martin B ^b   Gelenberg, Allan ^c   Dunner, David L ^d   Hirschfeld, Robert ^e   Thase, Michael E ^f   Russell, James ^e   Lydiard, R Bruce ^g   Crits Christoph, Paul ^h   Gallop, Robert ^h   Todd, Linda ^a   Hellerstein, David ⁱ   Goodnick, Paul ^j   Keitner, Gabor ^b   Stahl, Stephen M ^k   Halbreich, Uriel ^l  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ BETH ISRAEL MEDICAL CENTER   (United States)

^j UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY AT BUFFALO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYPERICUM PERFORATUM EXTRACT;

ABDOMINAL PAIN; ADULT; ARTICLE; CAUCASIAN; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; STATISTICAL ANALYSIS; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 0035906295     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.15.1978     Document Type: Article

References (58)

1. Why patients use alternative medicine: Results of a national study
2. St John's wort for depression
3. St. John's wort for depression: An overview and meta-analysis of randomized clinical trials
4. A rating scale for depression
5. Therapie von Depression Zustanden mit Hypericin
6. Depressive Verstimmungen
7. Beeinflussung klimakterischer Depressionen
8. Behandlung depressiver Zustande mit Hypericin
9. Zur Therapie depressiver Verstimmungen in der Praxis
10. Zur Therapie depressiver Verstimmungen
11. Psychotonin M versus Imipramin in der Chirurgie
12. Therapie depressiver Zustande
13. "Alternative" Depressionsbehandlung mit einem Hypericum Extrakt
14. Wirksamkeit des Johanniskrautextraktes tes LI 160 bei depressiver Verstimmung
15. Behandlung depressiver Syndrome mit Hypericum (Johanniskraut): Eine placebokontrollierte Doppelblind-studie
16. Hypericum-Extrakt bei Depressionen: Eine Wirksame
17. Ergebnisse von Messungen der kognitiven Leistungsfähigkeit bei Patienten unterder Therapie mit Johanniskraut
18. Johanniskraut-extrakt zur ambulanten therapie der depression
19. Ambulante Behandlung leichter und mittelschwerer depressiver Vetstimmungen
20. Behandlung leichter bis mittelschwerer Depressionen
21. Hypericum treatment of mild depressions with somatic symptoms
22. Effectiveness and tolerance of the Hypericum extract LI 160 compared to maprotiline: A multi-center double-blind study
23. Multicenter double-blind study examining the antidepressant effectiveness of the Hypericum extract LI 160
24. Placebo-controlled double-blind study examining the effectiveness of an Hypedcum preparation in 105 mildly depressed patients
25. Clinical trial on neurosymptoms; a placebo-controlled, randomized double-blind study
26. Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: Randomized double-blind study in 135 outpatients
27. Behandlung depressiver Verstimmungen mit einem hochkonzentrierten Hypericumpräparat: Eine multizentrische plazebokontrollierte Doppenblind-studie
28. L1 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients and #151; a controlled 6-week clinical trial
29. Efficacy and tolerability of St John's wort extract L1 160 versus imipramine in patients with severe depressive episodes according to lCD- 10
30. Hypericum treatment of mild-moderate depression in a placebo-controlled study: A prospective, double-blind, randomized, placebo-controlled, multicenter study
31. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomized multicentre study of treatment for eight weeks
32. Comparison of an extract of Hypericum (LI 160) and sertraline in the treatment of depression: A double-blind, randomized pilot study
33. Equivalence of St John's wort extract (Ze 117) and fluoxetine: A randomized, controlled study in mild-moderate depression
34. Comparison of St John's wort and imipramine for treating depression: Randomized controlled trial
35. A structured interview guide for the Hamilton Depression Rating scale
36. Commentary: Has Hypericum found its place in antidepressant treatment?
37. The placebo control in clinical trials (a view from the FDA)
38. A comparison of placebo responders and nonresponders in subgroups of depressive disorder
39. A comparison of placebo response with major depressive disorder in patients recruited through newspaper advertising versus consultation referrals
40. Placebos, drug effects, and study design: A clinician's guide
41. Run-in periods in randomized trials: Implications for the application of results in clinical practice
42. Threats to the validity of clinical trials employing enrichment strategies for sample selection
43. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects
44. Perspectives on the fifth revision of the Declaration of Helsinki
45. Helsinki discord? A controversial declaration
46. Clinical global impressions
47. An inventory for measuring depression
48. The assessment of anxiety status by rating
49. The course, morbidity, and costs of depression
50. Time to recovery, chronicity, and levels of psychopathology in major depression
51. Second thoughts about safety of St John's wort
52. Alternative medicine meets science
53. Alternative medicine: Learning from the past, examining the present, advancing to the future
54. Alternative medicine: The risks of untested and unregulated remedies